UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI)

Bioorganic & medicinal chemistry letters, 2001-08, Vol.11 (16), p.2061-2065

2001

Volltextzugriff (PDF)

1532: Serum BPSA is A Better Predictor of Prostate Enlargement than Either Total PSA or Free PSA in Men without Prostate Cancer

The Journal of urology, 2004-04, Vol.171 (4), p.403-403

2004

Volltextzugriff (PDF)

1560. Pharmacokinetics–Pharmacodynamics (PK-PD) of Gepotidacin (GEP) Against Escherichia coli in Murine Pyelonephritis and Thigh Infection Models

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S569-S569

2019

Volltextzugriff (PDF)

1658: Effects of Prostate Biopsy on PSA Isoforms in men With BPH and Cancer

The Journal of urology, 2004-04, Vol.171 (4), p.438-438

2004

Volltextzugriff (PDF)

1659: Effects of Finasteride and Saw Palmetto on BPSA, Propsa, and cPSA in Men with Benign Prostatic Hyperplasia

The Journal of urology, 2004-04, Vol.171 (4), p.438-439

2004

Volltextzugriff (PDF)

1660: Propsa Improves Prostate Cancer Detection and Tumor Aggressiveness in PSA Range 2.0 - 3.9 NG/ML

The Journal of urology, 2004-04, Vol.171 (4), p.439-439

2004

Volltextzugriff (PDF)

1661: Comparison of %FPSA, %BPSA, [-2]PPSA/FPSA, and [- 2]PPSA/BPSA for Prostate Cancer Detection in men With total Serum PSA Concentrations Between 4 and 10 NG/NL

The Journal of urology, 2004-04, Vol.171 (4), p.439-439

2004

Volltextzugriff (PDF)

1662: Volume-Based Evaluation of the Ratio of Precursor Prostate-Specific Antigen Isoforms in the Detection of Prostate Cancer

The Journal of urology, 2004-04, Vol.171 (4), p.439-440

2004

Volltextzugriff (PDF)

248S-649266, a Novel Siderophore Cephalosporin: Efficacy against Klebsiella pneumoniae producing NDM-1 or KPC in rat lung infection model with recreated humanized exposure profile of 2 gram dose with 1 hour and 3 hours infusion

Open forum infectious diseases, 2014-12, Vol.1 (suppl_1), p.S106-S107

2014

Volltextzugriff (PDF)

Abstract 576: Immunohistochemistry and radioimaging with hJAA-11 antibody to the Thomsen-Friedenreich antigen: Potential theranostic application for breast cancer

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.576-576

2016

Volltextzugriff (PDF)

Adoption of Policies to Treat Tobacco Dependence in U.S. Medical Groups

American journal of preventive medicine, 2010-11, Vol.39 (5), p.449-456

2010

Volltextzugriff (PDF)

Antiguos colaboradores

Sheehy Manual de Urgencia de Enfermería, p.xii-xii

Volltextzugriff (PDF)

Are multiple markers the future of prostate cancer diagnostics?

Clinical Biochemistry, 2004-07, Vol.37 (7), p.519-528

2004

Volltextzugriff (PDF)

Axillofemoral bypass: A critical reappraisal of its role in the management of aortoiliac occlusive disease

The American journal of surgery, 1979-01, Vol.138 (1), p.117-128

1979

Volltextzugriff (PDF)

Bacterial resistance to leucyl-tRNA synthetase inhibitor GSK2251052 develops during treatment of complicated urinary tract infections

Antimicrobial agents and chemotherapy, 2015-01, Vol.59 (1), p.289-298

2015

Volltextzugriff (PDF)

Benign Prostate-specific Antigen (BPSA) in Serum Is Increased in Benign Prostate Disease

Clinical chemistry (Baltimore, Md.), 2003-02, Vol.49 (2), p.253-259

2003

Volltextzugriff (PDF)

Benign prostatic hyperplasia‐associated prostate‐specific antigen (BPSA) shows unique immunoreactivity with anti‐PSA monoclonal antibodies

European journal of biochemistry, 2000-07, Vol.267 (13), p.4040-4045

2000

Volltextzugriff (PDF)

“BPSA,” a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia

Urology (Ridgewood, N.J.), 2000, Vol.55 (1), p.41-45

2000

Volltextzugriff (PDF)

Challenges of antibacterial discovery revisited

Annals of the New York Academy of Sciences, 2010-12, Vol.1213 (1), p.5-19

2010

Volltextzugriff (PDF)

Chapter 16 - Validation of Landscape-Scale Decision Support Models That Predict Vegetation and Wildlife Dynamics

Models for Planning Wildlife Conservation in Large Landscapes, 2009, p.415-448

2009

Volltextzugriff (PDF)

ChemInform Abstract: Synthesis and Activity of Analogues of SB-219383: Novel Potent Inhibitors of Bacterial Tyrosyl tRNA Synthetase

ChemInform, 2001-04, Vol.32 (16), p.no-no

2001

Volltextzugriff (PDF)

Clandestine Capabilities and Technological Diffusion Risks

International security, 2020-10, Vol.45 (2), p.194-198

2020

Volltextzugriff (PDF)

Clinical utility of proPSA and “benign” PSA when percent free PSA is less than 15

Urology (Ridgewood, N.J.), 2004-12, Vol.64 (6), p.1160-1164

2004

Volltextzugriff (PDF)

The CMS State Innovation Models Initiative and Improved Health Information Technology and Care Management Capabilities of Physician Practices

Medical care research and review, 2021-08, Vol.78 (4), p.350-360

2021

Volltextzugriff (PDF)

Comparison of mupirocin susceptibility of nasal and nonnasal Staphylococcus aureus isolates

Diagnostic microbiology and infectious disease, 1994-11, Vol.20 (3), p.171-174

1994

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(114)

Publikationsform

Sprache

Englisch
(149)
Spanisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI)

1532: Serum BPSA is A Better Predictor of Prostate Enlargement than Either Total PSA or Free PSA in Men without Prostate Cancer

1560. Pharmacokinetics–Pharmacodynamics (PK-PD) of Gepotidacin (GEP) Against Escherichia coli in Murine Pyelonephritis and Thigh Infection Models

1658: Effects of Prostate Biopsy on PSA Isoforms in men With BPH and Cancer

1659: Effects of Finasteride and Saw Palmetto on BPSA, Propsa, and cPSA in Men with Benign Prostatic Hyperplasia

1660: Propsa Improves Prostate Cancer Detection and Tumor Aggressiveness in PSA Range 2.0 - 3.9 NG/ML

1661: Comparison of %FPSA, %BPSA, [-2]PPSA/FPSA, and [- 2]PPSA/BPSA for Prostate Cancer Detection in men With total Serum PSA Concentrations Between 4 and 10 NG/NL

1662: Volume-Based Evaluation of the Ratio of Precursor Prostate-Specific Antigen Isoforms in the Detection of Prostate Cancer

248S-649266, a Novel Siderophore Cephalosporin: Efficacy against Klebsiella pneumoniae producing NDM-1 or KPC in rat lung infection model with recreated humanized exposure profile of 2 gram dose with 1 hour and 3 hours infusion

Abstract 576: Immunohistochemistry and radioimaging with hJAA-11 antibody to the Thomsen-Friedenreich antigen: Potential theranostic application for breast cancer

Adoption of Policies to Treat Tobacco Dependence in U.S. Medical Groups

Antiguos colaboradores

Are multiple markers the future of prostate cancer diagnostics?

Axillofemoral bypass: A critical reappraisal of its role in the management of aortoiliac occlusive disease

Bacterial resistance to leucyl-tRNA synthetase inhibitor GSK2251052 develops during treatment of complicated urinary tract infections

Benign Prostate-specific Antigen (BPSA) in Serum Is Increased in Benign Prostate Disease

Benign prostatic hyperplasia‐associated prostate‐specific antigen (BPSA) shows unique immunoreactivity with anti‐PSA monoclonal antibodies

“BPSA,” a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia

Challenges of antibacterial discovery revisited

Chapter 16 - Validation of Landscape-Scale Decision Support Models That Predict Vegetation and Wildlife Dynamics

ChemInform Abstract: Synthesis and Activity of Analogues of SB-219383: Novel Potent Inhibitors of Bacterial Tyrosyl tRNA Synthetase

Clandestine Capabilities and Technological Diffusion Risks

Clinical utility of proPSA and “benign” PSA when percent free PSA is less than 15

The CMS State Innovation Models Initiative and Improved Health Information Technology and Care Management Capabilities of Physician Practices

Comparison of mupirocin susceptibility of nasal and nonnasal Staphylococcus aureus isolates

Suchergebnisse filtern